Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...

This week, Bobbi Conner talks with MUSC's Dr. Thomas Curran about the increase in colon cancer in younger adults and options ...

Today, doctors are increasingly looking at the genetic makeup of each patient’s tumor to guide treatment decisions.

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments. Genetic testing is a laboratory method ...

So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

FDA has announced it has approved the first genetic test that can help some colorectal cancer patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. March is Colon Cancer Awareness Month, an important time to ...

My cousin, who's in her 30s, was recently diagnosed with colorectal cancer. I've always thought of colorectal cancer as ...

SALT LAKE CITY, Utah (Good Things Utah) – Colorectal cancer is the second most common cancer and the third leading cause of cancer related deaths in men and women under age 50. According to the ...